Selected research
Industry Growth & Trends
Global Mice Model Genetic Engineering Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Mice Model Genetic Engineering market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Mice Model Genetic Engineering is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Mice Model Genetic Engineering is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Mice Model Genetic Engineering is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Mice Model Genetic Engineering market include B BIOCYTOGEN, Charles River Laboratories, Cyagen Biosciences, Gempharmatech, genOway, ingenious targeting laboratory, Ozgene Pty Ltd., Taconic Biosciences, Inc. and PolyGene AG, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Mice Model Genetic Engineering market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Mice Model Genetic Engineering market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Mice Model Genetic Engineering market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Mice Model Genetic Engineering.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Mice Model Genetic Engineering market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Mice Model Genetic Engineering Market by Company
B BIOCYTOGEN
Charles River Laboratories
Cyagen Biosciences
Gempharmatech
genOway
ingenious targeting laboratory
Ozgene Pty Ltd.
Taconic Biosciences, Inc.
PolyGene AG
THE JACKSON LABORATORY
Yale School of Medicine
University of North Carolina
University of Nebraska Medical Center
Monash University
UMass Chan Medical School
University of Bonn
Columbia University
The University of Arizona
The Weizmann Institute of Science
The Hebrew University of Jerusalem
The Technion – Israel Institute of Technology
Hadassah BrainLabs
Mice Model Genetic Engineering Segment by Type
CRISPR Knockout
CRISPR Knockin
Random Insertions
ES Cell Modification (homologous recombination)
Others
Mice Model Genetic Engineering Segment by Application
Pharmaceutical Companies
Biotechnology Companies
Academic & Research Facilities
Contract Research & Manufacturing Organizations
Mice Model Genetic Engineering Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mice Model Genetic Engineering market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Mice Model Genetic Engineering and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mice Model Genetic Engineering.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Mice Model Genetic Engineering companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- CRISPR Knockout
- CRISPR Knockin
- Random Insertions
- ES Cell Modification (homologous recombination)
- Others
Applications
- Pharmaceutical Companies
- Biotechnology Companies
- Academic & Research Facilities
- Contract Research & Manufacturing Organizations
Companies covered
- B BIOCYTOGEN
- Charles River Laboratories
- Cyagen Biosciences
- Gempharmatech
- genOway
- ingenious targeting laboratory
- Ozgene Pty Ltd.
- Taconic Biosciences, Inc.
- PolyGene AG
- THE JACKSON LABORATORY
- Yale School of Medicine
- University of North Carolina
- University of Nebraska Medical Center
- Monash University
- UMass Chan Medical School
- University of Bonn
- Columbia University
- The University of Arizona
- The Weizmann Institute of Science
- The Hebrew University of Jerusalem
- The Technion – Israel Institute of Technology
- Hadassah BrainLabs
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Mice Model Genetic Engineering Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Mice Model Genetic Engineering Market Size by Region (2021-2032)
- 1.4.1 Global Mice Model Genetic Engineering Market Size by Region (2021-2026)
- 1.4.2 Global Mice Model Genetic Engineering Market Size by Region (2027-2032)
- 1.5 Key Regions Mice Model Genetic Engineering Market Size (2021-2032)
- 1.5.1 North America Mice Model Genetic Engineering Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Mice Model Genetic Engineering Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Mice Model Genetic Engineering Market Size Growth Rate (2021-2032)
- 1.5.4 South America Mice Model Genetic Engineering Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Mice Model Genetic Engineering Market Size Growth Rate (2021-2032)
2 Mice Model Genetic Engineering Market by Type
- 2.1 Type Introduction
- 2.1.1 CRISPR Knockout
- 2.1.2 CRISPR Knockin
- 2.1.3 Random Insertions
- 2.1.4 ES Cell Modification (homologous recombination)
- 2.1.5 Others
- 2.2 Global Mice Model Genetic Engineering Market Size by Type
- 2.2.1 Global Mice Model Genetic Engineering Market Size Overview by Type (2021-2032)
- 2.2.2 Global Mice Model Genetic Engineering Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Mice Model Genetic Engineering Market Size Forecasted by Type (2027-2032)
- 2.3 Global Mice Model Genetic Engineering Market Size by Regions
- 2.3.1 North America Mice Model Genetic Engineering Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Mice Model Genetic Engineering Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Mice Model Genetic Engineering Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Mice Model Genetic Engineering Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Mice Model Genetic Engineering Market Size Breakdown by Type (2021-2026)
3 Mice Model Genetic Engineering Market by Application
- 3.1 Type Introduction
- 3.1.1 Pharmaceutical Companies
- 3.1.2 Biotechnology Companies
- 3.1.3 Academic & Research Facilities
- 3.1.4 Contract Research & Manufacturing Organizations
- 3.2 Global Mice Model Genetic Engineering Market Size by Application
- 3.2.1 Global Mice Model Genetic Engineering Market Size Overview by Application (2021-2032)
- 3.2.2 Global Mice Model Genetic Engineering Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Mice Model Genetic Engineering Market Size Forecasted by Application (2027-2032)
- 3.3 Global Mice Model Genetic Engineering Market Size by Regions
- 3.3.1 North America Mice Model Genetic Engineering Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Mice Model Genetic Engineering Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Mice Model Genetic Engineering Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Mice Model Genetic Engineering Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Mice Model Genetic Engineering Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Mice Model Genetic Engineering Industry Trends
- 4.2 Mice Model Genetic Engineering Industry Drivers
- 4.3 Mice Model Genetic Engineering Industry Opportunities and Challenges
- 4.4 Mice Model Genetic Engineering Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Mice Model Genetic Engineering Revenue (2021-2026)
- 5.2 Global Mice Model Genetic Engineering Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Mice Model Genetic Engineering Key Company Headquarters & Area Served
- 5.4 Global Mice Model Genetic Engineering Company, Product Type & Application
- 5.5 Global Mice Model Genetic Engineering Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Mice Model Genetic Engineering Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Mice Model Genetic Engineering Players Market Share by Revenue in 2025
- 5.6.3 2025 Mice Model Genetic Engineering Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 B BIOCYTOGEN
- 6.1.1 B BIOCYTOGEN Company Information
- 6.1.2 B BIOCYTOGEN Business Overview
- 6.1.3 B BIOCYTOGEN Mice Model Genetic Engineering Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 B BIOCYTOGEN Mice Model Genetic Engineering Product Portfolio
- 6.1.5 B BIOCYTOGEN Recent Developments
- 6.2 Charles River Laboratories
- 6.2.1 Charles River Laboratories Company Information
- 6.2.2 Charles River Laboratories Business Overview
- 6.2.3 Charles River Laboratories Mice Model Genetic Engineering Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Charles River Laboratories Mice Model Genetic Engineering Product Portfolio
- 6.2.5 Charles River Laboratories Recent Developments
- 6.3 Cyagen Biosciences
- 6.3.1 Cyagen Biosciences Company Information
- 6.3.2 Cyagen Biosciences Business Overview
- 6.3.3 Cyagen Biosciences Mice Model Genetic Engineering Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Cyagen Biosciences Mice Model Genetic Engineering Product Portfolio
- 6.3.5 Cyagen Biosciences Recent Developments
- 6.4 Gempharmatech
- 6.4.1 Gempharmatech Company Information
- 6.4.2 Gempharmatech Business Overview
- 6.4.3 Gempharmatech Mice Model Genetic Engineering Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Gempharmatech Mice Model Genetic Engineering Product Portfolio
- 6.4.5 Gempharmatech Recent Developments
- 6.5 genOway
- 6.5.1 genOway Company Information
- 6.5.2 genOway Business Overview
- 6.5.3 genOway Mice Model Genetic Engineering Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 genOway Mice Model Genetic Engineering Product Portfolio
- 6.5.5 genOway Recent Developments
- 6.6 ingenious targeting laboratory
- 6.6.1 ingenious targeting laboratory Company Information
- 6.6.2 ingenious targeting laboratory Business Overview
- 6.6.3 ingenious targeting laboratory Mice Model Genetic Engineering Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 ingenious targeting laboratory Mice Model Genetic Engineering Product Portfolio
- 6.6.5 ingenious targeting laboratory Recent Developments
- 6.7 Ozgene Pty Ltd.
- 6.7.1 Ozgene Pty Ltd. Company Information
- 6.7.2 Ozgene Pty Ltd. Business Overview
- 6.7.3 Ozgene Pty Ltd. Mice Model Genetic Engineering Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Ozgene Pty Ltd. Mice Model Genetic Engineering Product Portfolio
- 6.7.5 Ozgene Pty Ltd. Recent Developments
- 6.8 Taconic Biosciences, Inc.
- 6.8.1 Taconic Biosciences, Inc. Company Information
- 6.8.2 Taconic Biosciences, Inc. Business Overview
- 6.8.3 Taconic Biosciences, Inc. Mice Model Genetic Engineering Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Taconic Biosciences, Inc. Mice Model Genetic Engineering Product Portfolio
- 6.8.5 Taconic Biosciences, Inc. Recent Developments
- 6.9 PolyGene AG
- 6.9.1 PolyGene AG Company Information
- 6.9.2 PolyGene AG Business Overview
- 6.9.3 PolyGene AG Mice Model Genetic Engineering Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 PolyGene AG Mice Model Genetic Engineering Product Portfolio
- 6.9.5 PolyGene AG Recent Developments
- 6.10 THE JACKSON LABORATORY
- 6.10.1 THE JACKSON LABORATORY Company Information
- 6.10.2 THE JACKSON LABORATORY Business Overview
- 6.10.3 THE JACKSON LABORATORY Mice Model Genetic Engineering Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 THE JACKSON LABORATORY Mice Model Genetic Engineering Product Portfolio
- 6.10.5 THE JACKSON LABORATORY Recent Developments
- 6.11 Yale School of Medicine
- 6.11.1 Yale School of Medicine Company Information
- 6.11.2 Yale School of Medicine Business Overview
- 6.11.3 Yale School of Medicine Mice Model Genetic Engineering Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Yale School of Medicine Mice Model Genetic Engineering Product Portfolio
- 6.11.5 Yale School of Medicine Recent Developments
- 6.12 University of North Carolina
- 6.12.1 University of North Carolina Company Information
- 6.12.2 University of North Carolina Business Overview
- 6.12.3 University of North Carolina Mice Model Genetic Engineering Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 University of North Carolina Mice Model Genetic Engineering Product Portfolio
- 6.12.5 University of North Carolina Recent Developments
- 6.13 University of Nebraska Medical Center
- 6.13.1 University of Nebraska Medical Center Company Information
- 6.13.2 University of Nebraska Medical Center Business Overview
- 6.13.3 University of Nebraska Medical Center Mice Model Genetic Engineering Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 University of Nebraska Medical Center Mice Model Genetic Engineering Product Portfolio
- 6.13.5 University of Nebraska Medical Center Recent Developments
- 6.14 Monash University
- 6.14.1 Monash University Company Information
- 6.14.2 Monash University Business Overview
- 6.14.3 Monash University Mice Model Genetic Engineering Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 Monash University Mice Model Genetic Engineering Product Portfolio
- 6.14.5 Monash University Recent Developments
- 6.15 UMass Chan Medical School
- 6.15.1 UMass Chan Medical School Company Information
- 6.15.2 UMass Chan Medical School Business Overview
- 6.15.3 UMass Chan Medical School Mice Model Genetic Engineering Revenue, Global Share and Gross Margin (2021-2026)
- 6.15.4 UMass Chan Medical School Mice Model Genetic Engineering Product Portfolio
- 6.15.5 UMass Chan Medical School Recent Developments
- 6.16 University of Bonn
- 6.16.1 University of Bonn Company Information
- 6.16.2 University of Bonn Business Overview
- 6.16.3 University of Bonn Mice Model Genetic Engineering Revenue, Global Share and Gross Margin (2021-2026)
- 6.16.4 University of Bonn Mice Model Genetic Engineering Product Portfolio
- 6.16.5 University of Bonn Recent Developments
- 6.17 Columbia University
- 6.17.1 Columbia University Company Information
- 6.17.2 Columbia University Business Overview
- 6.17.3 Columbia University Mice Model Genetic Engineering Revenue, Global Share and Gross Margin (2021-2026)
- 6.17.4 Columbia University Mice Model Genetic Engineering Product Portfolio
- 6.17.5 Columbia University Recent Developments
- 6.18 The University of Arizona
- 6.18.1 The University of Arizona Company Information
- 6.18.2 The University of Arizona Business Overview
- 6.18.3 The University of Arizona Mice Model Genetic Engineering Revenue, Global Share and Gross Margin (2021-2026)
- 6.18.4 The University of Arizona Mice Model Genetic Engineering Product Portfolio
- 6.18.5 The University of Arizona Recent Developments
- 6.19 The Weizmann Institute of Science
- 6.19.1 The Weizmann Institute of Science Company Information
- 6.19.2 The Weizmann Institute of Science Business Overview
- 6.19.3 The Weizmann Institute of Science Mice Model Genetic Engineering Revenue, Global Share and Gross Margin (2021-2026)
- 6.19.4 The Weizmann Institute of Science Mice Model Genetic Engineering Product Portfolio
- 6.19.5 The Weizmann Institute of Science Recent Developments
- 6.20 The Hebrew University of Jerusalem
- 6.20.1 The Hebrew University of Jerusalem Company Information
- 6.20.2 The Hebrew University of Jerusalem Business Overview
- 6.20.3 The Hebrew University of Jerusalem Mice Model Genetic Engineering Revenue, Global Share and Gross Margin (2021-2026)
- 6.20.4 The Hebrew University of Jerusalem Mice Model Genetic Engineering Product Portfolio
- 6.20.5 The Hebrew University of Jerusalem Recent Developments
- 6.21 The Technion – Israel Institute of Technology
- 6.21.1 The Technion – Israel Institute of Technology Company Information
- 6.21.2 The Technion – Israel Institute of Technology Business Overview
- 6.21.3 The Technion – Israel Institute of Technology Mice Model Genetic Engineering Revenue, Global Share and Gross Margin (2021-2026)
- 6.21.4 The Technion – Israel Institute of Technology Mice Model Genetic Engineering Product Portfolio
- 6.21.5 The Technion – Israel Institute of Technology Recent Developments
- 6.22 Hadassah BrainLabs
- 6.22.1 Hadassah BrainLabs Company Information
- 6.22.2 Hadassah BrainLabs Business Overview
- 6.22.3 Hadassah BrainLabs Mice Model Genetic Engineering Revenue, Global Share and Gross Margin (2021-2026)
- 6.22.4 Hadassah BrainLabs Mice Model Genetic Engineering Product Portfolio
- 6.22.5 Hadassah BrainLabs Recent Developments
7 North America
- 7.1 North America Mice Model Genetic Engineering Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Mice Model Genetic Engineering Market Size by Country (2021-2026)
- 7.3 North America Mice Model Genetic Engineering Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Mice Model Genetic Engineering Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Mice Model Genetic Engineering Market Size by Country (2021-2026)
- 8.3 Europe Mice Model Genetic Engineering Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Mice Model Genetic Engineering Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Mice Model Genetic Engineering Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Mice Model Genetic Engineering Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Mice Model Genetic Engineering Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Mice Model Genetic Engineering Market Size by Country (2021-2026)
- 10.3 South America Mice Model Genetic Engineering Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Mice Model Genetic Engineering Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Mice Model Genetic Engineering Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Mice Model Genetic Engineering Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst